In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Regional heterogeneity in the oxygenation reserve of women with syndrome-x

Session Moderated ePosters session 2: frontiers in viability imaging

Speaker Elizabeth Hillier

Congress : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Stress CMR
  • Session type : Moderated Posters
  • FP Number : 51

Authors : E Hillier (Montreal,CA), M El Harram (Montreal,CA), S Hawkins (Montreal,CA), M G Friedrich (Montreal,CA), L Pilote (Montreal,CA)

Authors:
E Hillier1 , M El Harram2 , S Hawkins1 , M G Friedrich1 , L Pilote1 , 1McGill University Health Centre - Montreal - Canada , 2Mcgill University - Montreal - Canada ,

On behalf: MUHC CMR Group

Citation:
European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii22

INTRODUCTION: The pathophysiology of women presenting with acute coronary syndrome with no obstructive coronary artery disease, termed Syndrome-X, remains incompletely understood. Microvascular dysfunction of the coronaries and the myocardium have been suggested as a potential mechanism of disease. However, cardiovascular magnetic resonance imaging (CMR) studies investigating microvascular disease have presented conflicting results. Oxygenation-Sensitive CMR (OS-CMR), combined with a breathing maneuver, has emerged as a powerful tool to investigate the Myocardial Oxygenation Reserve (MORE) of the myocardium.

PURPOSE: This study aims to assess microvascular dysfunction in women with Syndrome-X when compared to age-controlled healthy women utilizing OS-CMR.

METHODS: Fourteen Syndrome-X patients (mean age 54.6+/-6.58 years) and eighteen age-controlled healthy participants (mean age 52.7+/-3.90 years) underwent a CMR scan on a 3T Siemens scanner. Functional parameters were obtained from 2- and 4-chamber long axis standard SSFP cine images using the biplanar method. OS-CMR parameters were obtained from Oxygenation Sensitive (OS) images obtained in the basal and mid-ventricular short-axis. A combined breathing maneuver of 60 seconds of paced hyperventilation followed by a maximal breath-hold was performed. Global MORE values were obtained as a percent change in signal intensity from the beginning of the breath hold to the 30 second timepoint. Three methods were used to assess regional homogeneity. Radial difference, circumferential difference, and combined difference OS values were obtained from analyzing the endocardial and epicardial layers of the myocardium independently. Radial difference is the sum of the absolute differences between the endo- and epicardium in each of the myocardial segments. Circumferential difference is the sum of the differences between myocardial segments within the endo- and epicardium. Combined difference is a sum of radial and circumferential differences.

RESULTS: There was no significant difference in age, body mass index, body surface area, or cardiac output between the Syndrome-X and the healthy control participants. Syndrome-X patients had a significantly lower left ventricular ejection fraction than healthy control participants (76.45+/-6.88 vs. 71.5+/-5.89, p<0.05). Global myocardial oxygenation reserve values were not significantly different in Syndrome-X (6.90+/-6.59) when compared to healthy controls (5.06+/-4.47). Syndrome-X patients had a significantly higher radial (p=0.026), circumferential (p=0.0037), and combined difference (p=0.0026) when compared to healthy participants.

CONCLUSIONS: While the global myocardial oxygenation response between women with Syndrome-X and healthy control women was not significant, significant heterogeneity within the myocardium is present. This may indicate that heterogenous microvascular dysfunction is present in this patient population.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are